BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9404951)

  • 21. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
    Salmi P; Karlsson T; Ahlenius S
    Eur J Pharmacol; 1994 Feb; 253(1-2):67-73. PubMed ID: 7912199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431.
    Shiosaki K; Asin KE; Britton DR; Giardina WJ; Bednarz L; Mahan L; Mikusa J; Nikkel A; Wismer C
    Eur J Pharmacol; 1996 Dec; 317(2-3):183-90. PubMed ID: 8997599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dopamine D1 receptor agonists in rats trained to discriminate dihydrexidine.
    Gleason SD; Witkin JM
    Psychopharmacology (Berl); 2006 May; 186(1):25-31. PubMed ID: 16575553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydrexidine--the first full dopamine D1 receptor agonist.
    Salmi P; Isacson R; Kull B
    CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine.
    Wade MR; Nomikos GG
    Psychopharmacology (Berl); 2005 Nov; 182(3):393-9. PubMed ID: 16075289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
    J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for specific involvement of dopamine D1 and D2 receptors in the regulation of body temperature in the rat.
    Salmi P; Jimenez P; Ahlenius S
    Eur J Pharmacol; 1993 Jun; 236(3):395-400. PubMed ID: 8102971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.
    Nielsen EB; Andersen PH
    Eur J Pharmacol; 1992 Aug; 219(1):35-44. PubMed ID: 1397048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D1/D5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro.
    Gorelova NA; Yang CR
    J Neurophysiol; 2000 Jul; 84(1):75-87. PubMed ID: 10899185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
    Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
    Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats.
    Steele TD; Hodges DB; Levesque TR; Locke KW
    Pharmacol Biochem Behav; 1997 Oct; 58(2):477-83. PubMed ID: 9300608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D
    Mailman RB; Yang Y; Huang X
    Eur J Pharmacol; 2021 Feb; 892():173760. PubMed ID: 33279520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional differentiation of multiple dopamine D1-like receptors by NNC 01-0012.
    Sugamori KS; Hamadanizadeh SA; Scheideler MA; Hohlweg R; Vernier P; Niznik HB
    J Neurochem; 1998 Oct; 71(4):1685-93. PubMed ID: 9751203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats.
    Katz JL; Kopajtic TA; Terry P
    Behav Pharmacol; 2006 Jun; 17(4):303-9. PubMed ID: 16914948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
    Shieh GJ; Walters DE
    Eur J Pharmacol; 1996 Sep; 311(2-3):103-7. PubMed ID: 8891588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
    Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB
    Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
    Wise RA; Carlezon WA
    Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.